Multiple injections of thyrotropin releasing hormone fail to reverse learning and memory deficits in rats with lesions of the nucleus basalis of meynert

Behavioural Brain Research

Volumn 136, Issue 2, 2002, Pages 433-438

  Santucci, Anthony C ^a   Perez, Sarah ^a  

^a MANHATTANVILLE COLLEGE   (United States)

Author keywords

Alzheimer's disease; Learning; Memory; Morris water maze; Nucleus basalis of meynert; Thyrotropin releasing hormone

Indexed keywords

PROTIRELIN;

ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FOREBRAIN; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; MEYNERT BASAL NUCLEUS; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; TREATMENT FAILURE;

ALZHEIMER DISEASE; ANIMALS; BASAL NUCLEUS OF MEYNERT; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY DISORDERS; PARASYMPATHETIC NERVOUS SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; THYROTROPIN-RELEASING HORMONE;

EID: 0037111908     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00195-X     Document Type: Article

References (44)

1. Akaike M., Kato N., Ohno H., Kobayashi T. Hyperactivity and spatial maze learning impairment of adult rats with temporary neonatal hypothyroidism. Neurotoxicology and Teratology. 13:1991;317-322.
2. Bennett GW, Ballard TM, Watson CD, Fone KCF. Effect of neuropeptides on cognitive function. Exp Gerontol 32: 451-69.
3. Dekker A.J.A.M., Connor D.J., Thal L.J. The role of cholinergic projections from the nucleus basalis in memory. Neuroscience Biobehavioral Reviews. 15:1991;299-317.
4. Dekker A.J., Gage F.H., Thal L.J. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience. 48:1992;111-119.
5. Dekker A.J., Thal L.J. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements. Brain Research. 584:1992;55-63.
6. Drago F., Coppi G., Antonuzzo P.A., Valerio C., Genazzani A.A., Grasi M., Raffaele R., Scapagnini U. Effects of RGH 2202 on cognitive and motor behavior of the rat. Neurobiology of Aging. 17:1996;67-71.
7. Fischer W., Bjorklund A., Chen K., Gage F.H. NGF improves spatial memory in aged rodents as a function of age. The Journal of Neuroscience. 11:1991;1889-1906.
8. Giovannini M.G., Casamenti F., Nistri A., Paloi F., Pepeu G. Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. British Journal of Pharmacology. 102:1991;363-368.
9. Haroutunian V., Kanof P.D., Davis K.L. Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor. Brain Research. 487:1989;200-203.
10. Hayashi M., Patel A.J. An interaction between thyroid hormone and nerve growth factor in the regulation of choline acetyltransferase activity in neuronal cultures, derived from the septal-diagonal band region of the embryonic rat brain. Developmental Brain Research. 36:1987;109-120.
11. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. The Journal of Neuroscience. 6:1996;2155-2162.
12. Horita A., Carino M.A., Zabawska J., Lai H. TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats. Peptides. 10:1989;121-124.
13. Inanami O., Meguro K., Ohno K., Sato A. Contribution of cholinergic vasodilators on the increase in cerebral cortical blood flow responses to the intravenous administration of thyrotropin releasing hormone in anesthetized rats. Neuroscience Letters. 88:1988;184-188.
14. Miyamoto M., Hirai K., Takahashi H., Kato K., Nishiyama M., Okada H., Nagaoka A. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents. European Journal of Pharmacology. 238:1993;181-189.
15. Mandel R.J., Gage F.H., Thal L.J. Spatial learning in rats: Correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage. Experimental Neurology. 104:1989;208-217.
16. Mellow A.M., Sunderland T., Cohen R.M., Lawlor B.A., Hill J.L., Newhouse P.A., Cohen M.R., Murphy D.L. Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease. Psychopharmacology. 98:1989;403-407.
17. Mitsuma T., Nogimori T. Influence of the route of administration of thyrotrophin-releasing hormone concentration in the mouse brain. Experientia. 6:1983;620-623.
18. Miyamoto M., Narumi S., Nagaoka A., Coyle J.T. Effects of continuous infusion of cholinergic drugs on memory impairments in rats with basal forebrain lesions. Pharmacology and Experimental Therapeutics. 248:1989;825-835.
19. Molchan S.E., Mellow A.M., Lawlor B.A., Weigartner H.J., Cohen R.M., Cohen M.R., Sunderland T. TRH attenuates scopolamine-induced memory impairment in humans. Psychopharmacology. 100:1990;84-89.
20. Morris R.G.M. Spatial location does not require the presence of local cues. Learning and Motivation. 12:1981;239-260.
21. Noda Y., Furukawa K., Kohayakawa H., Oka M. Effects of RGH-2202 on behavioral deficits after focal cerebral ischemia in rats. Pharmacology Biochemistry and Behavior. 52:1995;695-699.
22. Ogasawara T., Itoh Y., Tamura M., Ukai Y., Yoshikuni Y., Kimura K. NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems. Pharmacology Biochemistry and Behavior. 53:1996;391-399.
23. Ogasawara T., Nakagawa Y., Ukai Y., Tamura M., Kimura K. NS-3(CG3703), a TRH analog, ameliorates scopolamine-induced memory disruption in rats. Pharmacology Biochemistry and Behavior. 51:1995;929-934.
24. Ogasawara T., Ukai Y., Tamura M., Kimura K. NS-3(CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats. Pharmacology Biochemistry and Behavior. 50:1995;499-503.
25. Ogawa N., Asanuma M., Hirata H., Chou H., Kondo Y., Ogawa S., Mori A. Distinction between declarative memory and procedural memory using 8-arm radial maze task: Biphasic effects of thyrotropin releasing hormone on scopolamine-induced amnesia. Research Communications in Psychology Psychiatry and Behavior. 17:1982;1-15.
26. Oh J.D., Butcher L.L., Woolf N.J. Thyroid hormone modulates the development of cholinergic terminal fields in the rat forebrain: relation to nerve growth factor receptor. Developmental Brain Research. 59:1991;133-142.
27. Osterweil D., Syndulko K. Hypothyroidism and central nervous system function in older adults. Facts and Research in Gerontology. 1991;97-103. Serdi, Paris.
28. Patel A.J., Hayashi M., Hunt A. Selective persistent reduction in choline acetyltransferase activity in basal forebrain of the rat after thyroid deficiency during early life. Brain Research. 422:1987;182-185.
29. Rami A., Patel A.J., Rabié A. Thyroid hormone and development of the rat hippocampus: morphological alterations in granule and pyramidal cells. Neuroscience. 19:1986;1217-1226.
30. Santucci A.C., Haroutunian V. Nucleus basalis lesions impair memory in rats trained on nonspatial and spatial discrimination tasks. Physiology and Behavior. 45:1989;1025-1031.
31. Santucci A.C., Haroutunian V., Bierer L.M., Davis K.L. Approaches to the treatment of Alzheimer's disease. Lister R.G., Weingartner H.J., Perspective on Cognitive Neuroscience. 1991;467-483 Oxford University Press, New York.
32. Santucci A.C., Kanof P.D., Haroutunian V. Fetal transplant-induced restoration of spatial memory in rats with lesions of the nucleus basalis of Meynert. Journal of Neural Transplantation and Plasticity. 2:1991;65-74.
33. Santucci A.C., Kanof P.D., Haroutunian V. Cholinergic marker deficits induced by lesions of the NBM are attenuated by nerve growth factor in young, but not in aged, F344 rats. Brain Research. 609:1993;327-332.
34. Santucci A.C., Kanof P.D., Haroutunian V. Transient enhancement of cholinergic neurochemical markers induced by NGF in aged F344 rats. Dementia. 6:1995;179-184.
35. Shinoda M., Matsuo A., Toide K. Pharmacological studies of a novel prolyl endopeptidase inhibitor, JTP-4819, in rats with middle cerebral artery occlusion. European Journal of Pharmacology. 305:1996;31-38.
36. Shinoda M., Miyazkai A., Toide K. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis. Behavioral Brain Research. 99:1999;17-25.
37. Stwertka S.A., Vincent G.P., Gamzu E.R., MacNeil D.A., Verderese A.G. TRH protection against memory retrieval deficits is independent of endocrine effects. Pharmacology Biochemistry & Behavior. 41:1991;145-152.
38. Suzuki A., Kurosawa M. Thyrotropin releasing hormone (TRH) excites the cholinergic system originating in the nucleus basalis of Meynert. Society for Neuroscience Abstract. 17:1991;974.
39. Williams L.R., Varon S., Peterson G.M., Wictorin K., Fischer W., Bjorklund A., Gage F.H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proceedings of the National Academy of Science USA. 83:1986;9231-9235.
40. Williams L.R. Exogenous nerve growth factor stimulates choline acetyltransferase activity in aging Fischer 344 male rats. Neurobiology of Aging. 12:1991;39-46.
41. Yamamoto M., Iwai A., Ozawa Y. Effects of a new TRH analogue, YM-14673, on disturbance of passive avoidance in senescence-accelerated mice. Pharmacology Biochemistry & Behavior. 35:1990;727-729.
42. Yamamoto M., Tamura A., Kirino T., Shimizu-Sasamata M., Sano K. Effects of thyrotropin-releasing hormone on behavioral disturbances in middle cerebral artery-occluded rats. European Journal of Pharmacology. 197:1991;117-123.
43. Yamamura M., Kinoshita K., Nakagawa H., Ishida R. Pharmacological study of TA-0910, a new thyrotropin releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats. Japanese Journal of Pharmacology. 55:1991;241-253.
44. Yamazaki M., Matsuoka N., Maeda N., Kuratani K., Ohkubo Y., Yamaguchi I. FR121196, a potential antidementia drug, ameliorates the impaired memory of rat in the Morris water maze. Pharmacology and Experimental Therapeutics. 272:1995;256-263.